-
Mashup Score: 1
Since early in her higher education studies, Lucrèce Delicat-Loembet has found genetics fascinating. With sickle cell disease common in her home nation of Gabon, it was perhaps no surprise that this would be the focus of her career. Today, she has three vital elements to her work—both as a researcher and teacher at the Faculty of Science at the Masuku University of Science and Technology (USTM) in Franceville, Gabon, and as founding president of the non-governmental organisation (NGO) Sickle Cell Disease Organization of Gabon (SCDOGa).
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Why FDA approval of sickle cell gene therapy is a ‘big deal’ - 4 month(s) ago
Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’
Source: www.pbssocal.orgCategories: General Medicine News, PediatricsTweet-
Hear @cececalhounMD in @NewsHour on why FDA approval of #SickleCell gene therapy is a ‘big deal’: https://t.co/DRMf8Fc9g6
-
-
Mashup Score: 9SenatoItaliano - 6 month(s) ago
Canale YouTube ufficiale del Senato della Repubblica
Source: www.youtube.comCategories: General Medicine News, Onc News and JournalsTweet-
On Nov 20, we will be at the Senate of the Republic in Rome with Raffaella Colombatti @UniPadova to present our Commission on #SickleCell Disease 🇮🇹 📽️You can follow the launch online from 9.30h (Italian) https://t.co/8EjPptljW6 Full programme for the event https://t.co/7ypuPG1OTX
-
-
Mashup Score: 0Potential Cure for Sickle Cell Clears Hurdle for Approval - 6 month(s) ago
FDA advisors suggest the benefits of gene therapy outweigh risks of off-target editing
Source: www.medpagetoday.comCategories: General Medicine News, General NewsTweet-
"The risk is theoretical." -- Tabassum Ahsan, PhD, of @cityofhope, discussing the risk of off-target gene editing with the investigational agent exagamglogene autotemcel (exa-cel) for #sicklecell disease. https://t.co/MWLK6XUA9D
-
-
Mashup Score: 2
Sickle cell disease is the most common inherited pathological haemoglobinopathy. Over the past 30 years, disease-related morbidity and mortality have …
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Really excited to see our review published. Thanks to @jkw4444 and @RaviTalatiDO for helping to make this happen, and thanks to @LancetChildAdol for creating necessary space for #SickleCell https://t.co/OU6L7uqmJS https://t.co/jiKYEwPQE2
-
-
Mashup Score: 0Improving outcomes in sickle cell disease - 6 month(s) ago
Commissioners Dr Michael R DeBaun and Dr Dipty Jain, and Lwimba Kasongo, MPH, who has lived experience of sickle cell disease, outline some of the obstacles …
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
@JanetDaby 📽️ To support this @UKParliament launch, we have recorded a new video on #sicklecell disease with @lwimbaa, Prof Michael DeBaun, and Prof Dipty Jain Watch it @TheLancet YouTube channel https://t.co/s8skVGYXgf
-
-
Mashup Score: 0
Researchers reported that deferiprone safety and efficacy was comparable with deferoxamine for treating iron overload in pediatric patients, according to a post hoc analysis published in Pediatric Blood & Cancer. Researchers compared the safety and efficacy of defe riprone and deferoxamine in patients aged 17 years or younger with sickle cell disease or other anemias who participated in the phase IIIb/IV FIRST trial. Deferoxamine is injected subcutaneously while deferiprone is an oral agent. Children who
Source: docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet-
Oral deferiprone yielded outcomes comparable to subcutaneous deferoxamine for pediatric patients with sickle cell disease. #sicklecell #hematology https://t.co/iJnMdMBcnH https://t.co/01ULJCaz1P
-
-
Mashup Score: 1Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies - 7 month(s) ago
Timothy S Olson
Source: www.thelancet.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Debate: #transplantation versus #genetherapy for haemoglobinopathies ➡️Timothy Olson, Children's Hosp of Philadelphia: allogeneic haematopoietic stem-cell #transplantation ➡️Mark Waters, @UCSFBenioffOAK: gene therapy #bmtsm #sicklecell #thalasaemia https://t.co/XCIlQL97JG
-
-
Mashup Score: 2BODHI • โพธิ์ (@bodhi.indy) • Instagram photo - 7 month(s) ago
43 likes, 2 comments – bodhi.indy on October 11, 2023: “𝙅𝙤𝙞𝙣 𝘽𝙊𝘿𝙃𝙄 𝙞𝙣 𝙎𝙪𝙥𝙥𝙤𝙧𝙩𝙞𝙣𝙜 𝘾𝙝�…”
Source: www.instagram.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Join us tomorrow evening at Bodhi Restaurant in #Indianapolis to raise funds for our #sicklecell and #thalassemia program @RileyChildrens! @RileyKids @IU_Health @IUNewsroom https://t.co/jxcOSV8uPr
-
-
Mashup Score: 1
Explore the current issue of The Lancet Haematology, a monthly journal dedicated to publishing content that advocates change in, or illuminates, haematological clinical practice
Source: www.thelancet.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In the issue, #Correspondence on #sicklecell disease 1⃣ A set of letters discuss the data underlying the global burden of sickle cell disease in 2021 #GBD 2⃣ A second set discusses the strategies and priorities outlined in the SCD Commission https://t.co/GGrf76fYkU https://t.co/sGX2Z8Ervv
-
"The DrepaDreams project, in which she works with colleague Manuella Bondo, aims to lift the spirits and dreams of affected children and help them focus on the future" #sicklecell New Profile on Lucrèce Delicat-Loembet 🇬🇦https://t.co/MthIGEcHO7